Friday, April 3, 2026
24.8 C
Bengaluru

Pharma Marketing & The Reinvention

[wpfilebase tag=file id=105 tpl=download-button /]

Inside this Issue

1. Pharma Marketing & the Reinvention of the Pharma Company by  Salil Kallianpur

Digitization and shifting customer expectations are redefining the traditional role of a pharma company – how can marketing keep pace?

2. 5 Minute Guide to Professional Sales Management in in the Digital Age by Anirudha Sengupta

A quick reminder on what it takes to succeed in the age of shrinking in-clinic time and expanding information sources

3. Market Segmentation for the Digital Age by Vivek Hattangadi

The wealth of information contained in the digital footprint of customers, means that segmentation is no longer simply about age, gender and a few interests

4. Book Review: Catalyst by Chandramouli Venkatesan  by Rajeev Kumar

A career growth manual that emphasizes professional growth as an outcome of “real individual growth”

5. AIOCD Market Highlights  by Ameesh Masurekar

Market highlights for the month of February 2018

Download the issue here: PDF

Hot this week

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Topics

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...
spot_img

Related Articles

spot_imgspot_img